Formation and Function Sample Clauses

Formation and Function. Promptly after the Effective Date, CollaGenex and Atrix will each appoint two senior representatives to a committee (the "Marketing Advisory Board") that shall have oversight for any activity under this Agreement for the Territory. CollaGenex will select an individual to serve as chairman of the Marketing Advisory Board for the initial 12 months. Thereafter, the chairmanship will rotate between an Atrix member and a CollaGenex member every 12 months. Each of CollaGenex and Atrix shall bear its own travel and lodging expenses incurred in connection with the attendance of its representatives at meetings of the Marketing Advisory Board. Except as set forth in Section 5.01(c), the Marketing Advisory Board will be consulted by both Parties on all major decisions in the marketing of each Product in the Territory, including, without limitation, in the following areas as they relate to each Product:
AutoNDA by SimpleDocs
Formation and Function. The Parties will form a joint steering committee (“JSC”) promptly following the Effective Date, that will oversee and manage the collaboration of the Parties under this Agreement, including: (i) the review and approval of all proposed Project Schedules and recommending any amendments thereto (subject to agreement by the Parties), (ii) receiving and reviewing updates on development activities and other activities contemplated by this Agreement, (iii) review and approval of development activities or any deliverables set forth in any Project Schedule, (iv) ensuring the cooperation and participation of the Parties in the performance of a Project Schedule, (v) reviewing the recommendations, plans and other activities in support of this Agreement, (vi) resolving disputes escalated to the JSC in accordance with Section 6.6 (Escalation Process), and (vii) all other matters related to this Agreement or any development activities expressly delegated to the authority of the JSC hereunder.
Formation and Function. The Parties may form a joint project team (the “JPT”) composed of a reasonable number of representatives from each Party with appropriate professional and technical qualifications, and ongoing familiarity with the development activities contemplated by this Agreement, in the areas of project management, clinical, regulatory, technical and quality. The JPT may manage the development activities under a Project Schedule and confer on a regular basis regarding the status and progress of the development activities. One member of the JPT from each Party will prepare and provide a summary update of the JPT’s activities to the JSC in advance of each JSC [*] meeting.
Formation and Function. Promptly after the Effective Date, Nycomed and Acusphere will each appoint two (2) senior representatives to a committee (the "Steering Committee") that shall have oversight for any activity under this Agreement for the Territory. Acusphere will appoint one of their representatives as chairman of the Steering Committee for the initial twelve (12) months. Thereafter, the chairmanship will rotate between a Nycomed member and an Acusphere member every twelve (12)
Formation and Function. Within 30 days following the Effective Date, the Parties will establish a joint steering committee (the “Joint Steering Committee”) pursuant to this Section 2. For clarity, the Joint Steering Committee under this Agreement may be composed of the same individuals, and may also function as, the Joint Steering Committee under the Co-Marketing and Distribution Agreement entered into by the Parties concurrently with this Agreement.
Formation and Function. The Parties will form a Joint Steering Committee promptly following the Effective Date. The JSC will serve as a coordinating body for (i) strategic considerations related to the development and commercialization of the RUO Assays and (ii) the transitioning from the RUO Phase and to the IVD Phase if and when the IVD Kits Option is duly exercised. Among other things, the JSC will perform the following functions: (i) review the Product Development Plan and the Product Commercialization Plan, (ii) receive and review updates on Activities contemplated by the Product Development Plan and the Product Commercialization Plan, (iii) serve as a forum for resolving disputes arising in Joint Subcommittees, and (iv) all other matters related to this Agreement expressly delegated to the authority of the JSC hereunder, including allocation of responsibilities for customer support and the potential transfer of assay manufacturing by Oncocyte to Bio-Rad.
Formation and Function. Promptly after the Effective Date, Warner and Onyx will each appoint 3 representatives to a management committee (the "STEERING COMMITTEE") that shall have overall management responsibility for the Collaboration, subject to the terms of this Agreement. Warner will select an individual to serve as chairman of the Steering Committee for the initial 12 months. Thereafter, chairmanship will rotate between an Onyx member and a Warner member every 12 months. The Steering Committee will be charged with overseeing and managing the entire Collaboration, including oversight of the activities and decisions of the Research Management Committee. In addition, the role of the Steering Committee will be to: (1) coordinate the Parties' activities hereunder; (2) resolve problems or settle disagreements that are unresolved by the Research Management Committee, the Development Team and the Joint Marketing Committee unless otherwise indicated in this Agreement; (3) approve allocations of tasks and resources required to carry out the goals of the Collaboration; (4) review and approve the Research Plan, the Development Plan and Budget for each Licensed Product, and the Marketing Plan and Budget for each Licensed Product that has achieved Regulatory Approval in the Shared Territory; (5) designate Licensed Products for Development as provided in Section 3.6; (6) encourage and facilitate ongoing cooperation between the parties; (7) coordinate and monitor the payments and repayments to be made by and between the parties; and (8) perform such other functions as appropriate to further the purposes of this Agreement as determined by the parties. All decisions of the Steering Committee shall be by unanimous consent of its members. Any disputes or disagreements within the Steering Committee shall be resolved pursuant to Section 2.6.
AutoNDA by SimpleDocs
Formation and Function. A collaboration committee (the “Collaboration Committee”) shall oversee and manage activities under this Agreement, including the collaboration generally, developing, approving and implementing a Joint Marketing Plan, reviewing ordering patterns, reviewing the List Price, developing and providing current quarter and rolling [*] forecasts, considering Approved Entities, maintaining the Parties’ alignment on product positioning, launch plans, planning outreach events, and considering necessary actions towards competitive threats.
Formation and Function. Within [***] after the Effective Date, the Parties shall form a joint steering committee (“Joint Steering Committee” or “JSC”) to oversee and manage the collaboration of the Parties under this Agreement. The responsibilities of the JSC shall include: (i) making such changes, or having such changes made, to the Work Plan as it deems necessary to accomplish Work Plan objectives, and reviewing and approving any other proposed amendments to the Work Plan, (ii) receiving and reviewing updates on Activities and other activities contemplated by this Agreement, (iii) reviewing and approving Activities or any Deliverables set forth in the Work Plan, (iv) ensuring the cooperation of the Parties in the performance of the Work Plan, and that the Parties are meeting their commitments for both human and financial support and are each fulfilling all of their respective obligations hereunder, (v) reviewing the recommendations, plans and other activities in support of this Agreement, (vi) resolving disputes escalated to the JSC in accordance with Section 2.6, and (vii) all other matters related to this Agreement or any Activities expressly delegated to the authority of the JSC hereunder or as the Parties otherwise agree.

Related to Formation and Function

  • Information and Reporting The Adviser shall provide the Trust and its respective officers with such periodic reports concerning the obligations the Adviser has assumed under this Agreement as the Trust may from time to time reasonably request.

  • Information and Access 5.1 The Customer shall:

  • Information and Reports The contractor will provide all information and reports required by the Acts, the Regulations, and directives issued pursuant thereto and will permit access to its books, records, accounts, other sources of information, and its facilities as may be determined by the sponsor or the Federal Aviation Administration to be pertinent to ascertain compliance with such Nondiscrimination Acts And Authorities and instructions. Where any information required of a contractor is in the exclusive possession of another who fails or refuses to furnish the information, the contractor will so certify to the sponsor or the Federal Aviation Administration, as appropriate, and will set forth what efforts it has made to obtain the information.

  • Inspection and Reporting Each Grantor shall permit the Collateral Agent, or any agent or representatives thereof or such attorneys, accountant or other professionals or other Persons as the Collateral Agent may designate (at Grantors’ sole cost and expense) (i) to examine and make copies of and abstracts from any Grantor’s Records and books of account, (ii) to visit and inspect its properties, (iii) to verify materials, leases, Instruments, Accounts, Inventory and other assets of any Grantor from time to time, and (iv) to conduct audits, physical counts, appraisals, valuations and/or examinations at the locations of any Grantor. Each Grantor shall also permit the Collateral Agent, or any agent or representatives thereof or such attorneys, accountants or other professionals or other Persons as the Collateral Agent may designate to discuss such Grantor’s affairs, finances and accounts with any of its directors, officers, managerial employees, attorneys, independent accountants or any of its other representatives. Without limiting the foregoing, the Collateral Agent may, at any time, in the Collateral Agent’s own name, in the name of a nominee of the Collateral Agent, or in the name of any Grantor communicate (by mail, telephone, facsimile or otherwise) with the Account Debtors of such Grantor, parties to contracts with such Grantor and/or obligors in respect of Instruments or Pledged Debt of such Grantor to verify with such Persons, to the Collateral Agent’s satisfaction, the existence, amount, terms of, and any other matter relating to, Accounts, Instruments, Pledged Debt, Chattel Paper, payment intangibles and/or other receivables.

Time is Money Join Law Insider Premium to draft better contracts faster.